Learn About Relapsing Multiple Sclerosis (RMS)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Atrium Health Neurology Specialty Care
Donna Graves is a Neurologist in Charlotte, North Carolina. Dr. Graves is rated as a Distinguished provider by MediFind in the treatment of Relapsing Multiple Sclerosis (RMS). Her top areas of expertise are Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Neuromyelitis Optica, and Optic Neuritis. Dr. Graves is currently accepting new patients.
Stanley Cohan is a Neurologist in Portland, Oregon. Dr. Cohan is rated as an Elite provider by MediFind in the treatment of Relapsing Multiple Sclerosis (RMS). His top areas of expertise are Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), CACH Syndrome, and Encephalitis.
Duke Neurological Disorders Clinic - Clinic 1L
F Lee Hartsell Iii is a Neurologist in Durham, North Carolina. Dr. Lee Hartsell Iii is rated as a Distinguished provider by MediFind in the treatment of Relapsing Multiple Sclerosis (RMS). His top areas of expertise are Neuromyelitis Optica, Optic Neuritis, Multiple Sclerosis (MS), and Relapsing Multiple Sclerosis (RMS). Dr. Lee Hartsell Iii is currently accepting new patients.
Summary: This study will evaluate the pharmacokinetics, pharmacodynamics, safety and tolerability of a new dosage of ofatumumab compared to the approved dosage of ofatumumab followed by extended treatment in participants with relapsing multiple sclerosis.
Summary: This study is a prospective, multi-center, randomized, double blinded, placebo-controlled study of OCR treatment-discontinuation in patients with early RMS. All eligible participants will be initiated on OCR using the standard approved administration schedule of two 300 mg infusions separated by 14 days (i.e., Days 0 and 14) for a total of 600 mg, followed by 600 mg infusions at Month 6,12, 18, an...